LONDON--(BUSINESS WIRE)--The prestigious European Association of Urology (EAU) has recognised the important role of cryotherapy in treating cancer of the prostate by including this therapy for the first time in its new guidelines on prostate cancer. Launched at the EAU’s recent 22nd annual Congress in Berlin, these guidelines support the use of cryosurgical ablation of the prostate (CSAP) as a possible alternative treatment method for patients with clinically localised cancer of the prostate.
